1,661 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Bought by Rakuten Securities Inc.

Rakuten Securities Inc. purchased a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,661 shares of the pharmacy operator’s stock, valued at approximately $43,000.

Several other large investors also recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Walgreens Boots Alliance by 38.0% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 469,612 shares of the pharmacy operator’s stock worth $12,262,000 after purchasing an additional 129,361 shares during the last quarter. Everence Capital Management Inc. increased its position in Walgreens Boots Alliance by 27.1% in the fourth quarter. Everence Capital Management Inc. now owns 72,610 shares of the pharmacy operator’s stock worth $1,896,000 after purchasing an additional 15,500 shares during the last quarter. Imprint Wealth LLC bought a new stake in Walgreens Boots Alliance in the fourth quarter worth $238,000. Sumitomo Mitsui Trust Holdings Inc. increased its position in Walgreens Boots Alliance by 12.4% during the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,077,336 shares of the pharmacy operator’s stock valued at $80,349,000 after acquiring an additional 339,143 shares during the last quarter. Finally, Louisiana State Employees Retirement System bought a new position in Walgreens Boots Alliance during the fourth quarter valued at $2,924,000. Institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

WBA has been the topic of a number of analyst reports. HSBC reiterated a “reduce” rating and set a $20.00 price objective (down previously from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Monday, February 26th. Truist Financial reiterated a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Morgan Stanley cut their price objective on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research report on Monday, April 1st. Finally, UBS Group cut their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 3rd. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $24.36.

Insider Buying and Selling

In other Walgreens Boots Alliance news, CFO Manmohan Mahajan acquired 6,000 shares of the stock in a transaction that occurred on Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Manmohan Mahajan purchased 6,000 shares of the firm’s stock in a transaction on Tuesday, April 2nd. The stock was acquired at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Inderpal S. Bhandari purchased 3,000 shares of the firm’s stock in a transaction on Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now owns 3,000 shares of the company’s stock, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders acquired a total of 13,456 shares of company stock valued at $270,423 over the last three months. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Stock Down 0.2 %

NASDAQ:WBA opened at $17.59 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $17.51 and a 1-year high of $36.14. The company has a 50-day moving average of $20.50 and a 200 day moving average of $21.95. The firm has a market cap of $15.18 billion, a PE ratio of -2.51, a price-to-earnings-growth ratio of 1.09 and a beta of 0.73. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The company had revenue of $37.05 billion during the quarter, compared to analyst estimates of $35.86 billion. During the same period in the prior year, the firm earned $1.16 earnings per share. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. As a group, research analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current fiscal year.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.